NYSE:CCM - Concord Medical Services Stock Price, Forecast & News

Concord Medical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "CCM."

Concord Medical Services Hldg Ltd (NYSE:CCM) released its quarterly earnings results on Wednesday, August, 24th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by $0.27. The firm earned $18.93 million during the quarter. View Concord Medical Services' Earnings History.

Concord Medical Services is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Concord Medical Services.

Headlines about CCM stock have trended very negative on Wednesday, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Concord Medical Services earned a daily sentiment score of -3.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Concord Medical Services.

Concord Medical Services saw a increase in short interest in December. As of December 31st, there was short interest totalling 3,100 shares, an increase of 10.7% from the December 15th total of 2,800 shares. Based on an average trading volume of 2,000 shares, the days-to-cover ratio is currently 1.6 days. Currently, 0.0% of the company's stock are sold short. View Concord Medical Services' Current Options Chain.

Some companies that are related to Concord Medical Services include Fulcrum Therapeutics (FULC), Starpharma (SPL), Innate Pharma (IPHYF), Mallinckrodt (MNK), BioCryst Pharmaceuticals (BCRX), Urovant Sciences (UROV), AnaptysBio (ANAB), Lexicon Pharmaceuticals (LXRX), Triple-S Management (GTS), Oxford Immunotec Global (OXFD), Catalyst Pharmaceuticals (CPRX), HEXO (HEXO), Meridian Bioscience (VIVO), BioSpecifics Technologies (BSTC) and Aptorum Group (APM).

Based on aggregate information from My MarketBeat watchlists, some companies that other Concord Medical Services investors own include The Carlyle Group (CG), Hi-Crush Partners (HCLP), NovaBay Pharmaceuticals (NBY), Altria Group (MO), Domtar (UFS), Biocept (BIOC), Corcept Therapeutics (CORT), DURECT (DRRX), Fibrocell Science (FCSC) and Gilead Sciences (GILD).

Shares of CCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CCM stock can currently be purchased for approximately $2.59.

Concord Medical Services has a market capitalization of $112.39 million and generates $27.76 million in revenue each year. The company earns $-34,160,000.00 in net income (profit) each year or ($1.20) on an earnings per share basis. Concord Medical Services employs 583 workers across the globe.View Additional Information About Concord Medical Services.

The official website for Concord Medical Services is http://www.concordmedical.com/.

Concord Medical Services' mailing address is 18/F TOWER A GLOBAL TRADE CENTER 36 NORTH THIRD RING ROAD, BEIJING F4, 100013. The company can be reached via phone at 86-10-5903-6688 or via email at [email protected]